Table 4: Univariate analysis of the clinical factors influencing the efficacy of Helicobacter  pylori eradication.

Principle parameterCase no.Eradication rate value

Age
60 years11182.0% (91)0.318
60 years7287.5% (63)
Sex
 Female9881.6% (80)0.316
 Male8587.1% (74)
Smoking
 (−)16883.3% (140)0.472
 (+)1593.3% (14)
Previous history of peptic ulcer
 (−)13881.9% (113)0.141
 (+)4591.1% (41)
HP eradication (per protocol)
 EAL-109075.6% (68)0.002
 EAL-149392.5% (86)
Compliance
 Good18384.2% (154)
 Poor00% (0)

EAL-10: esomeprazole/amoxicillin/levofloxacin triple therapy 10 days and EAL-14: esomeprazole/amoxicillin/levofloxacin triple therapy 14 days.